June 30, 2010 (Lure, France) – Vétoquinol, in collaboration with two other veterinary laboratories, is participating in a project organised by the Syndicat de l’Industrie du Médicament Vétérinaire (SIMV) to raise awareness of the need to treat pain in cattle.

The treatment of pain in cattle is generally less well developed in France than in neighbouring countries. A committee of independent experts, composed of six practicing veterinarians and academic researchers, was formed to formulate a set of recommendations in this area. They issued 28 final recommendations, which have been made available to practicing veterinarians in the form of a guide, and to breeders on a dedicated website: www.boreve.fr.

The French cattle market is substantial: more than 19 million heads. Vétoquinol commercialises three significant products for the treatment of pain in this market: Tolfine®, Lurocaïne® and Calmagine®.

“Virtually all diseases in cattle are painful, and call for analgesic treatment,” stated Matthieu Frechin, Managing Director of Vétoquinol. “Untreated pain reduces productivity. The goal of the Boreve-d project is to improve the well-being of animals, to promote the provision of medical care in an under-represented segment, and to enhance the relationship between veterinarians and breeders. This project fits in perfectly with our focused strategy.”



Press release